Lilly begins first clinical trial of antibody that targets SARS-CoV-2

Lilly begins first clinical trial of antibody that targets SARS-CoV-2

The antibody, isolated by the Canadian start-up AbCellera, was discovered and developed in just 3 months

  • 0 Likes

  • 0 Comments